Cancer Epidemiology Biomarkers & Prevention: 1 (7)

A case-control study of the etiology of Ewing's sarcoma.

D M Winn, F P Li, L L Robison, J J Mulvihill, A E Daigle and J F Fraumeni Jr

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 525-532;
Medical history and the risk of non-Hodgkin's lymphomas.

C La Vecchia, E Negri and S Franceschi

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 533-536;
Prostate-specific antigen levels and subsequent prostate cancer: potential for screening.

K J Helzlsouer, J Newby and G W Comstock

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 537-540;
Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer.

S Vijayakumar, T Karrison, R R Weichselbaum, S Chan, S F Quadri and A M Awan

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 541-545;
Association of serum ferritin levels with the risk of stomach cancer.

A Nomura, P H Chyou and G N Stemmermann

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 547-550;
Immunohistochemical evidence of p53 overexpression in gastric epithelial dysplasia.

M Rugge, Y H Shiao, P Correa, R Baffa and F DiMario

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 551-554;
Effects of breast cancer treatments on plasma nutrient levels: implications for epidemiological studies.

N Potischman, T Byers, L Houghton, M Root, T Nemoto and T C Campbell

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 555-559;
Cell proliferation in rat colon measured with bromodeoxyuridine, proliferating cell nuclear antigen, and [3H]thymidine.

F Richter, A Richter, K Yang and M Lipkin

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 561-566;
Urinary 6 beta-hydroxycortisol/cortisol ratios measured by high-performance liquid chromatography for use as a biomarker for the human cytochrome P-450 3A4.

L Joellenbeck, Z Qian, A Zarba and J D Groopman

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 567-572;
A prospective study of hprt mutant and mutation frequencies in treated cancer patients.

M Caggana, H L Liber, C N Coleman, P Mauch, J R Clark and K T Kelsey

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 573-580;
Impact of a physician intervention program to increase breast cancer screening.

M E Costanza, J G Zapka, D R Harris, D Hosmer, R Barth, V P Gaw, H L Greene and A M Stoddard

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 581-589;
Breast self-examination proficiency and training effects: women at increased risk of breast cancer.

M E Stefanek, P Wilcox and A M Huelskamp

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 591-596;
Apoptosis in the genesis and prevention of cancer.

H J Thompson, R Strange and P J Schedin

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 597-602;
Correspondence re: A. R. Kristal et al., evaluation of a test for abnormal rectal mucus for early detection of colon cancer. Cancer epidemiol. biomarkers & prev., 1: 303-306, 1992.

K Sakamoto

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 603-603;
Correspondence re: A.R. Kristal et al., evaluation of a test for abnormal rectal mucus for early detection of colon cancer. Cancer Epidemiol., Biomarkers & Prev., 1: 303-306, 1992.

A K Shamsuddin

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 603-604;
Salt intake and stomach cancer: some contrary evidence.

G D Friedman and J Parsonnet

Cancer Epidemiol Biomarkers Prev November 1 1992 1 (7) 607-608;

Main menu

User menu

Search

Table of Contents

Articles

Info for

About Cancer Epidemiology, Biomarkers & Prevention